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ABSTRACT
The causality dilemma between dysbiosis and cancer has given rise to numerous studies
both exploring the mechanisms behind cancer progression and the associative shifts in the
microbiota upon carcinogenesis. Aside from the hallmark study of Dr. Barry Marshall in
establishing the true causal relationship between Helicobacter pylori and gastric
adenocarcinoma, studies have only been successful in adding associative links of carcinogenesis
mediated by bacteria to the literature. The current field is limited in its ability to establish
causative relationships, and further work is needed to construct a reference community whose
physiological responses reflect global community responses. In this thesis, the organism
Lactobacillus acidophilus was selected as a pilot strain for the development of a novel
framework to establish the fitness and physiological changes that occur when bacteria engage the
human epithelial environment. The pilot strain was revived from the American Type Culture
Collection (ATCC), verified through 16S rRNA Sanger sequencing, and grown in its
conventional culture medium and human tissue culture medium to establish baseline growth rates
and gauge its physiological responses to an in vitro tumor microenvironment. A set of standard
conditions was proposed for growth under human tissue culture conditions. Finally, a metabolic
study and spot plate assay were performed to elucidate the anabolic deficits and viability of this
strain in human tissue culture medium, respectively. This research was performed to better
understand the environmental and metabolic requirements for this pilot strain to inhabit the
human epithelial environment and to establish a workflow that will set the foundation for an
appropriate clinical study to demonstrate the causative relationship between dysbiosis and
carcinogenesis.
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INTRODUCTION
The relationship between dysbiosis and carcinogenesis is still unclear, and there exists a
causality dilemma of whether dysbiosis is a cause or result of cancer progression. Ecosystems
such as the human microbiome are so complex that there are no ways to analyze the
metagenomic or metabolic characteristics of individual strains found to inhabit the host
microbiota, making it difficult to attribute true causal relationships between bacteria and cancer.
Demonstrated in 1984, there exists only one true established case of carcinogenesis
mediated by bacteria.1 As the first two postulates had been established by the literature, in an
attempt to fulfill Koch’s remaining postulates for pyloric Campylobacter (later recognized as
Helicobacter pylori), Dr. Barry Marshall drank a cultured broth of H. pylori to establish a
causative relationship between bacteria and gastritis, thought to lead to chronic infection, peptic
ulceration, and gastric adenocarcinoma. An endoscopy performed on the tenth day after infection
revealed histological evidence of gastritis and significant colonization by the bacterium, fulfilling
Koch’s third postulate that “the inoculation of these germs, taken from the original animal,
should produce the same disease in a susceptible animal.” Koch’s requirements for the final
postulate, that “the germs should be found in the diseased areas so produced in the animal,” were
met after subsequent Gram-stained specimens of the organism were identified as H. pylori.1 This
groundbreaking study set aside the speculation of the existence of oncogenic bacteria. However,
as research clearly cannot continue in this direction and experiments of this nature cannot be
repeated, the current path of studies on bacterial carcinogenesis is limited in scope.
In our research, the speculative links between bacteria and cancers of the head and neck,
particularly head-and-neck squamous cell carcinoma (HNSCC), have yet to be confirmed.
1

HNSCC is the seventh most common form of cancer and comprises over 5% of all cancer cases
worldwide.2-6 Both smoking and alcohol consumption are the greatest risk factors, and over 75%
of all cases of HNSCC can be attributed to a combination of these elements.3-5 Viral factors, such
as infection with carcinogenic strains of human papillomavirus (HPV), are an additional
confirmed risk factor. Yet despite the range of well-established risk factors, HNSCC and related
cancers have been seen to occur in those without a history of tobacco or alcohol use, and HPV is
seen in only a moderate proportion of cases.5 The host microbiome has been implicated in the
initiation and progression of HNSCC, and several mechanisms proposed to explain the
carcinogenesis mediated by dysbiosis are rapidly gaining interest. Moreover, several studies
noting associative changes in the microbiome have well-documented these shifts; however, the
field is limited in establishing the causative relationship as was done with H. pylori. In an ideal
situation, there exists a subset of variable, characterized microbes that can be used to gauge the
physiological responses of a reference community. Work needs to be completed to highlight
hallmark strains and construct a reference community whose physiological responses to stressor
conditions will be telling of global community responses, which will set up the framework for a
proper clinical study. The underlying premise is that microbes play a role, no matter how small,
in carcinogenesis – the precedent being that humans are not sterile organisms. There are several
studies that have characterized the local microbiota in regions of interest, but again the data is
missing on direct causative relationships.
The research completed was performed in a unique setting – a bacterial physiology lab
able to analyze bacterial responses located near our collaborator, a head-and-neck cancer lab
positioned to emulate the human epithelial environment and analyze organotypic tissue
2

responses. Together, collaboration between the two labs allowed us to characterize the growth
behavior and physiological responses of individual strains thought to be hallmark strains of a
reference community that is telling of the global host response. For this thesis, ATCC (American
Type Culture Collection) 4796 Lactobacillus acidophilus was selected as a pilot strain as it is
readily cultivable, found in normal and diseased tissue, and its complete genome is annotated.7,8
The specific strain was selected from a larger list of commensal and pathogenic bacterial strains
evaluated in proposed models for HNSCC in a grant from our cancer collaborator lab. A novel
framework was developed to establish the fitness and physiological changes that occur when
bacteria engage the human epithelial environment. The specific aims of this research were as
follows: 1) to establish baseline growth behavior of L. acidophilus in its conventional culture
medium, and 2) to characterize the physiological responses of L. acidophilus to exposure to a
human tissue culture medium. The completion of this thesis set the stage for characterizing the
transcriptional and adaptive responses of this bacterium to the human epithelial environment.

3

MATERIALS AND METHODS
Pilot Strain Revival and Verification
The materials for strain revival and propagation, including deMan, Rogosa, and Sharpe
(MRS) agar plates and broth, were prepared per ATCC recommendations (refer to Appendix B:
MRS Composition and Preparation). The strain was retrieved from the Andl lab in freeze-dried
double-vial preparation and was revived according to ATCC protocol. The freeze-dried pellet
was rehydrated in 5 mL of MRS broth and streaked on two MRS agar plates; after 48 hours,
isolated colonies were observed and inoculated in 1 mL of MRS broth. A series of several
overnight (O/N) cultures was carried out and a final inoculation was used to prepare a 20%
glycerol stock, which was placed in a -80°C freezer for joint lab use. A sub-stock was created
from the previous freezer stock to create a dedicated freezer stock for the Moore lab.
To verify the pilot strain, 16S amplicon analysis was utilized. DNA was extracted using
bead ablation followed by silica binding from an isolated colony derived from the Moore lab
freezer stock and stored at -20°C (refer to Appendix C: Reagents for DNA Extraction). The
isolated DNA was used in a PCR reaction using the “path_tail” set of primers for taxonomy
(refer to Appendix D: Primers for Taxonomy). A portion of the PCR reaction was run on an
agarose gel to roughly verify the length of the PCR reaction (~400-500 base pairs), and the
remaining PCR product was stored at 4°C. Afterward, the PCR product was cleaned to remove
primers, enzyme, and excess reagent using a silica column (refer to Appendix E: Reagents for
PCR Cleanup). An Applied Industrial Microbiology (AIM) sequencing primer, which anneals to
the 5’ portion of the Illumina tail and the sequencing read through to the other end, was then
used for Sanger sequencing of the V3-V4 region (Figure 1). The cleaned PCR samples were
4

prepared and sent for Sanger sequencing. The results were received in .seq and .ab1 format, and
the Sanger sequence was trimmed of bad base calls and primer sequences.
Growth Study – MRS
Preliminary growth studies were performed to determine both baseline growth rates and
optimal growth conditions for the pilot strain. Additionally, the growth of L. acidophilus in its
native medium, MRS broth, was analyzed under two different environmental conditions and
three different culture volumes. The environmental conditions were reproduced using two
different 96-well plate lids: low-evaporation and high-evaporation. This was done to vary the
levels of humidity and gas exchange; the low-evaporation lids allow for, as the name suggests,
lower rates of evaporation of the well volume, reducing the amount of gas exchange in the
system. Furthermore, the culture volumes used – 50, 100, and 150 μL – allowed us to establish
volume dependence on these cultures; different volumes simulate changes in the ratio of exposed
aerobic and anaerobic regions, representing different rates of gas exchange. To analyze growth,
turbidity measured at fixed intervals was used to estimate the biomass of each independent well.
The turbidity of bacterial cultures linearly correlates with biomass – this has been observed in
both bacterial and yeast cultures.9 In addition, bacterial density expresses the doubling time of a
bacterial culture – or the division rate, if the assumption that all the cells are of constant average
size is made.9 The outer edge wells of the plate were filled with water and the adjacent row was
left empty to act as a thermal barrier for the culture wells. An O/N stationary culture was diluted
1/100 in fresh MRS media, vortexed, and quickly spun down. The three different culture
volumes were pipetted into each well first, followed by the blank wells. The three replicate
samples, with their respective blank cultures, were grown for 24 hours in a continuously shaking
5

plate reader at 37°C, and turbidity at a wavelength of 600 nm (OD600) was read every five
minutes.
Growth Study – CCM
After baseline growth rates were established, as well as optimal culture conditions in a
96-well plate, growth of L. acidophilus in cell culture media was characterized to determine the
microbe’s response to human cell conditions. The cell culture media (CCM) utilized,
keratinocyte serum-free media (KSFM), was retrieved from the Andl lab and prepared with no
antibiotics and supplied with human recombinant Epidermal Growth Factor 1-53 (EGF 1-53) and
Bovine Pituitary Extract (BPE). The CCM was refrigerated at 4°C when not in use and allowed
to reach room temperature before inoculation. Three replicate 100 μL samples of CCM – as
established by the previous growth study – were inoculated with an O/N stationary culture, along
with their respective blanks, and grown for 24 hours in a low-evaporation lid 96-well plate in a
continuously shaking plate reader at 37°C, and turbidity at a wavelength of 600 nm was read
every five minutes.
As discussed in greater detail below, no noticeable growth was observed in any of the
CCM samples; therefore, a subsequent growth study was carried out to determine if CCM acts as
an inhibitor or spectator of microbial growth. An O/N stationary culture in MRS was divided into
two 500 μL aliquots. One aliquot was spun down, the supernatant was aspirated and discarded,
and the pellet was resuspended in 500 μL of CCM and placed on ice to create a 1X CCM stock
culture. A 1/100 dilution with this stock culture in fresh CCM was performed to create a 100%
CCM inoculation. A 1/100 dilution with the stock culture was also inoculated in 490 μL of CCM
and 500 μL of dH2O to create a 1:1 ratio of CCM and water. The second 500 μL aliquot was
6

used to create a 1/100 dilution in 490 μL of fresh MRS and 500 μL of CCM to create a 1:1 ratio
of MRS and CCM. The second aliquot was also used to create a 1/100 dilution in 490 μL of fresh
MRS and 500 μL of dH2O to create a 1:1 ratio of MRS and dH2O. Three replicate samples of
100 μL of each mixture, along with their respective blanks, were grown in a low-evaporation lid
96-well plate for 24 hours in a continuously shaking plate reader at 37°C, and turbidity at a
wavelength of 600 nm was read every five minutes.
Additionally, a short meta-analysis was conducted to compare the major metabolic
components in MRS and CCM to highlight any nutritional deficiencies in the media. The product
information sheets for the proprietary KSFM compositions were collected, and literature for their
original compositions was referenced.
EZ Metabolic Study
To further elucidate the metabolic requirements of L. acidophilus after a meta-analysis of
media substrates, a synthetic, rich defined medium (RDM) kit was used to control and exclude
major metabolite groups. A series of RDM compositions, along with negative controls, were
created from the kit using pre-prepared aliquots of each major group: MOPS modified rich
buffer, potassium phosphate dibasic solution, 20% glucose, ACGU solution, and supplement EZ
mixture of amino acids and cofactors (refer to Appendix F: MOPS EZ Rich Defined Medium Kit
Components). An O/N stationary culture was prepared from a freezer stock and inoculated into
three experimental cultures: full RDM, full RDM minus ACGU, and full RDM minus
supplement. Three negative cultures of MRS, CCM, and the full RDM, as well as previous
experimental trials from the growth study to confirm the lack of growth, were also prepared. The
cultures were placed in a 37°C shaking incubator and monitored for growth over 72 hours.
7

Spot Plate Assay
Upon completion of the growth studies of the pilot strain in human cell culture media,
after which it was concluded that the media could not support growth, a spot plate assay (SPA)
was performed to assess whether CCM is innocuous or harmful to L. acidophilus. For this
portion of the experiment, an overnight stationary culture of L. acidophilus was serially diluted
in both MRS and CCM to a countable concentration, plated on MRS agar, and the number of
colonies produced, in terms of colony-forming units per milliliter (CFU/mL), were compared to
assess their viability. The viability of these cultures in their respective media was analyzed in the
incubation environment of the human cell – the Andl lab human cell incubator (37°C, 5% CO2,
no shaking). An isolated colony from an MRS agar plate was used to create an O/N stationary
culture (~1010/mL), which was then diluted by a factor of 100 in two fresh aliquots of MRS and
CCM – these “stock” cultures were incubated in the Andl lab and serially diluted for the assay.
Dilutions based on observable turbidity were made each day to create new serial dilution stock
cultures; the original dilution window was set at 10-2, 10-4, 10-5, and 10-6 for both cultures. The
remaining stock cultures were placed in the Andl lab human cell incubator. Four replicate
samples of four appropriate serial dilutions were dispensed in 5 μL droplets in the following
manner: a pseudo-drop was formed on the pipette tip and gently placed on the agar plate; the
pipette tip was then inserted into the drop, and the micropipette was pushed till the second stop.
The spots were left to dry on the lab bench for 30 minutes and later placed agar-side down in the
Moore lab 37°C incubator. Growth was monitored after 12 hours and the plates were
subsequently flipped agar-side up to prevent condensation from disturbing the spots. After an
additional 12 hours, the stock cultures were removed from the Andl lab and turbidity was
8

observed to determine the next set of dilution windows. After the first round, similar turbidity to
the stock culture was noted in the MRS culture, so the dilution window was moved farther down
(10-2, 10-4, 10-6, 10-8); no noticeable turbidity was noted in the CCM culture, so the original
dilution window was kept for an additional 24 hours to allow for delayed growth. After the
second round, once again, similar turbidity to the stock culture was noted in the MRS culture, so
the dilution window was kept the same. However, no growth was noted in the CCM culture, so
the window was moved to a more concentrated window (10-2, 10-3, 10-4, 10-5), in hopes of
capturing colony formation. For the third and fourth round of the assay, similar turbidity from
previous rounds was noted in both cultures, so the former dilution windows were kept the same.
The plates were wrapped in parafilm to prevent drying and were refrigerated for storage.

9

RESULTS
Pilot Strain Revival and Verification
Upon NCBI BLAST, no complete match to the trimmed Sanger sequence was found;
however, near-perfect matches were observed with several closely related L. acidophilus strains,
with single mismatch results that suggested close strain-specific changes. Upon consultation with
Dr. Yooseph, it was revealed that the ATCC 4796 genome, currently sequenced as part of the
Human Microbiome Project (HMP), is currently in a draft stage and part of an NCBI cohort of L.
acidophilus strains; the representative annotated strain is L. acidophilus North Carolina Food
Microbiology (NCFM) (scaffold sequences, gene calls, and assemblies can be found online).8,10
A .fasta file of the ATCC 4796 16S rRNA sequence was used as a template to align the Sanger
sequence, resulting in a 100% match and complete verification of the strain.
The trimmed Sanger sequence was also BLASTed against both related Lactobacillus
(taxid:1578) and L. acidophilus (taxid:1579) organisms to support our confidence in the
identification of the pilot strain. After the sequences were aligned to the parameters, two
organisms from each group with identities less than 100% (~99.77%) were selected and aligned
to the trimmed Sanger sequence and compared with the experimental chromatogram (Figures 1
and 2). Among related species in the Lactobacillus genus, the organisms Lactobacillus casei and
Lactobacillus crispatus had a 99.77% identity to the Sanger sequence; both varied in position 24
with cytosine instead of adenine. Among related L. acidophilus strains, the two strains PP12 and
C11 also resulted in 99.77% identity to the Sanger sequence. The PP12 strain varied in position
191 with cytosine instead of guanine, and the C11 strain varied in position 289 with guanine
instead of thymine. These variable regions were compared to the Sanger chromatogram; in all
10

cases, the chromatogram peaks in the positions of interest were strong, distinct, and no other
significant fluorescent signals were noted in the annotated template read.

Figure 1: Sanger sequence and chromatogram aligned to closely-related species
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Figure 2: Sanger sequence and chromatogram aligned to closely-related strains

Growth Study – MRS
The data was imported, and the log2 transform and derivative values of each blankcorrected well were analyzed to determine optimal time windows for each environmental
condition (Figures 7-11). The use of log base 2 – as opposed to log base 10 – allows for
convenient representation of growth curves where one ordinate value represents a single division
when log base 2 of the bacterial density is plotted against time.11 Time windows when the
derivative remained at a maximum constant value, and where the log2 transform values versus
time gave a linear regression line, represented the doubling time of each culture condition – these
were used as a reference to compare the different volumes and environmental conditions. To find
optimal windows, the graphed curve of the blank-corrected derivative values was smoothed in
GraphPad Prism to the following parameters: 25 neighbors on each side, 2nd order of smoothing
12

polynomial. This was done to achieve a rough estimate of the curve peak. Values in the time
window from 755-790 minutes in the low-evaporation environment remained constant, whereas
values in the time window from 940-980 minutes in the high-evaporation environment remained
constant, represented by the peaks in Figure 8 and 9, respectively. The doubling time of each
culture condition, represented by the reciprocal of the slope of the linear regression line of each
culture condition during the selected time windows, was used as a reference to compare the
different volumes and environmental conditions (Figure 12). Independent t-tests (p < 0.05) were
conducted between each sample, revealing no significant difference in the doubling times
between low-evaporation and high-evaporation replicate samples for 50 μL culture volumes,
with a p-value of 0.1682. Additionally, there was no significant difference in the doubling times
between the 50 μL and 100 μL culture volumes under low-evaporation lids. However, there was
a significant difference in the doubling times between the two 100 μL cultures under both
environmental conditions, with a p-value of 0.0005.
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Figure 3: Turbidity of culture volumes of L. acidophilus under low/high-evaporation lids
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Figure 4: Derivative values of L. acidophilus under low-evaporation lid
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Figure 5: Derivative values of L. acidophilus under high-evaporation lid
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Figure 6: Log2 transform values of L. acidophilus under low-evaporation lid
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Figure 7: Log2 transform values of L. acidophilus under high-evaporation lid
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Figure 8: Doubling times of culture volumes of L. acidophilus
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Growth Study – CCM
As noted above, no significant growth was detected in the 100% CCM cultures;
therefore, culture ratios of CCM and MRS, as well as MRS and H2O, were inoculated and the
log2 transform and derivative values of each blank-corrected well were analyzed (Figures 1316). The GraphPad Prism smoothing operation was performed once more to give time windows
where the derivative remained at a constant value. The derivative remained constant at the time
window from 920-960 minutes for the 1:1 CCM-MRS cultures and from 1105-1145 minutes for
the 1:1 MRS-H2O cultures. Linear regression lines were generated for each culture condition and
the reciprocal slope values were calculated; the doubling times between the two culture ratios
were significantly different (p < 0.01) (Figure 17). Furthermore, literature was gathered on the
metabolic substrates of each media for comparison.
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Figure 9: Turbidity readings of L. acidophilus cultures in ratios of MRS, CCM, and H2O
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Figure 10: Derivative values of L. acidophilus in 1:1 ratio of CCM-MRS culture
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Figure 11: Derivative values of L. acidophilus in 1:1 ratio of MRS-H2O culture
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Figure 12: Log2 transform values of L. acidophilus in 1:1 culture ratios
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EZ Metabolic Study
The growth of each culture after incubation was noted in Table 1, denoted by plus/minus
signs to indicate levels of visible turbidity. No visible turbidity was noted in the three negative
inoculations, MRS, CCM, and Full RDM, as well as in the O/N inoculations in both CCM and
RDM w/o ACGU component. In both the 1:1 ratio of MRS and Full RDM and RDM w/o
Supplement EZ, similar heavy turbidity was recorded; yet in the O/N inoculations in MRS and
Full RDM, only moderate turbidity was observed.
Table 1: EZ Metabolic Study Observable Turbidity

Spot Plate Assay
After two consecutive 24-hour incubations and immediate refrigerator storage, the
number of colonies from each spot were counted and recorded in Table 2. The colony counts
were averaged and multiplied by their respective dilution factor as well as by the spot correction,
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the percentage of one mL (1000 uL / 5 μL spots = 200), to calculate the number of colonyforming units per mL (CFU/mL). Spots with solid lawns were designated as too numerous to
count (TNTC); standard deviation values were also calculated using the same mathematical
correction. For plates with two replicates, the value with the smallest error was prioritized and
used in the final graphical replication, with the exception of the 24-hour CCM culture (Figure
18). Upon analysis of the previous dilution, 10-2, the colony count average was 28.75; this
suggests a severe undercount of the colonies upon a 100-fold dilution that yielded an average of
1.25 colonies. Additionally, in order to adjust the variable spread, the third colony count was
omitted. The changes in viability, represented by CFU/mL in log base 10, as a function of
incubation time in each respective media, were recorded graphically below. In the MRS culture,
a significant bloom within the first 24 hours of inoculation was noted, followed by two
consecutive decreases in viability. A similar trend was noted in the CCM inoculation where a
significant decrease of viability was observed albeit not as severe as the MRS culture.
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Table 2: SPA Colony Count (CFU/mL)

SPA Viability (CFU/mL) in MRS and CCM

CFU/mL (log10)

10 9

0 Hours

10 8

24 Hours
48 Hours

10 7

72 Hours

10 6
10 5
10 4
MRS

CCM

Media Composition
Figure 14: Viability of L. acidophilus under in vitro human tissue culture conditions
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DISCUSSION
Analysis of Results
The 16S small ribosomal subunit (16S rRNA) gene is composed of nine hypervariable
regions termed V1-V9 with constant regions flanking either side; used for taxonomic research,
this gene has been used to characterize the composition of bacterial communities in the human
microbiome as well as soil and oceanic samples.12 Historically, sequencing the entire 16S rRNA
gene was limited by the length and depth of sequencing, so many protocols now focus on
sequencing shorter regions of the gene. In particular, V3 analysis was found to distinguish
bacteria to the genus level, and primers flanking the V3-V4 segments provide an optimal target
for sequencing and taxonomic classification.13,14 Moreover, analyses on the use of short
sequencing reads in the V1-V9 region found that paired-end sequencing of either the V3 or V4
region provided the most taxonomic resolution.12 The set of path_tail primers used are modified
Illumina sequencing primers for the amplification of the V3 and V4 regions of the 16S rRNA
gene and have widely different primer melting temperatures (Tm). Originally, there was an extra
cytosine at the 3’ end of the reverse primer; however, the Moore lab found that this led to greater
underrepresentation of the reverse read, so it was removed. The forward primer was initially
degenerate, containing a Q in the annealing portion of the forward primer; it was later removed
to allow for greater specificity when originally used for identifying pathogenic bacterial strains.
After comparing the sequence differences between related Lactobacillus and L.
acidophilus organisms on NCBI BLAST to the fluorescent base-pair calls on the chromatogram,
we are confident in our ability to distinguish our pilot strain from closely related organisms. This
verification process was integral in confirming that our studies utilized the same strain found in
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normal and diseased tissue. A limitation of this method is that L. acidophilus is reported to have
four ribosomal RNA loci mainly assembled around 260 kb, from which it follows that the V3
and V4 regions of these operons may vary in sequence.8 The reference genome lacks these
annotations and we were unable to locate each individual read. However, the V3 and V4 regions
were BLASTed against L. acidophilus NCFM, resulting in four matches – three 100% reads and
one read with a single mismatch, confirming the number of ribosomal RNA loci in L.
acidophilus.
The turbidity of L. acidophilus at OD600 was monitored over 24 hours in its established
culture medium to determine both baseline growth rates and optimal growth conditions. The
different plate lids and culture volumes allowed for the control of the levels of humidity and gas
exchange, and doubling rates were calculated by taking the reciprocal of the slope of the linear
regression line of log2 values where the derivative remained at a constant, maximum value. In
Figure 3, we observe classic bacterial growth curves among the samples with distinct lag,
exponential, and stationary phases. This behavior provides validation that the pilot strain behaves
similarly to other microbes despite the range of potential environmental stressors. The final
turbidity readings are greater in the larger culture volumes as well as the low-evaporation lids of
each group of cultures, which suggests that L. acidophilus prefers low gas-exchange levels with
the atmosphere and a primarily anaerobic environment. Moreover, the pilot strain reaches its
maximum growth rate notably earlier under the low-evaporation lid, further supporting this
claim. L. acidophilus is reportedly the least oxygen-tolerant species in the Lactobacillus genus,
utilizing a strictly homofermentative pathway of metabolism to produce lactic acid.15 The
Lactobacillus genus has been previously classified as an oxygen-tolerant group of organisms and
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several studies have found that certain species grown in aerobic conditions may have greater
acquired resilience to increased temperature and oxidative stress.16 For example, among the
genus, L. casei, L. plantarum, and L. sakei are among the most well-equipped organisms to
survive in aerobic conditions, possessing increased gene density coding for enzymes involved in
pyruvate metabolism, oxidative stress tolerance pathways, and components of the respiratory
chain.16 However, L. acidophilus is reported to undergo cell death when exposed to aerobic
environments, often presented during the homogenization and agitation steps of probiotic yogurt
production.17 While oxidative studies report that L. acidophilus has a limited capability of
scavenging reactive oxygen species, it contains low levels of NADH oxidase and NADH
peroxidase, enzymes critical in oxygen elimination from the cell; experimentally, this has led to
results demonstrating that increasing levels of oxygen lead to lower levels of lactic acid
produced.17 A wide range of doubling times was observed, with the low-evaporation 100 μL
culture averaging around 107 minutes; for reference, the standard Escherichia coli MG1655 K12 research strain has a doubling time of ~30 minutes at 37°C. Visualized in Figure 8, as there
was a significant difference in the doubling times between the 100 μL cultures, this volume was
considered as a baseline for future growth studies. As no significant difference was observed
between the 50 μL and 100 μL cultures under low-evaporation lids, the larger volume will
provide for less noise and is optimal for the analysis of subtle growth differences. Additionally,
the low-evaporation lids provide for a more anaerobic environment catered to the strain’s
metabolic and biochemical properties. Therefore, we propose that a 100 μL culture volume under
low-evaporation lids be the standard condition for the pilot strain. With that said, the observation
that L. acidophilus grows best under anaerobic conditions and with limited gas-exchange may
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prove helpful for future in vitro studies as the head-and-neck microenvironments are relatively
hypoxic.18
No significant growth was detected in cultures solely containing CCM, so cultures
containing mixtures of CCM and MRS were inoculated and graphical representations of turbidity
versus time were generated. In the 1:1 CCM-MRS cultures, the turbidity of each replicate well
climbed to a maximum value; however, we also note the early death phase of these cultures – a
phase not observed in the previous inoculations. This suggests that MRS may not be able to
sustain growth for long periods of time, an idea further discussed in the spot plate assay. More
importantly, based on both the turbidity readings and doubling times, the culture containing
CCM does not appear to hinder growth as compared to the 1:1 MRS-H2O replicates, which
suggests CCM does not act as an inhibitor. In the 1:1 MRS-H2O replicates, final doubling times
were observed to be about two-thirds of the 1:1 CCM-MRS cultures. In the span of 24 hours,
these replicates appear to take a longer time to reach exponential phase; this may be due to the
lack of nutrients and an overall lower ratio of substrate to total culture volume. By the time the
1:1 MRS-H2O replicates reach stationary phase, the 1:1 CCM-MRS culture is undergoing death
phase. Not shown are the turbidity readings of L. acidophilus inoculated in pure CCM, as no
recordable turbidity was observed – further confirmed by the EZ metabolic study. As the MRS
media used in this research was undefined, containing several crude components such as beef
extract, yeast extract, and proteose peptone, it was difficult to compare its exact substrates to
human tissue culture medium. Therefore, a defined medium from a study analyzing the growth
and metabolic requirements of L. acidophilus R-26 was referenced and used for comparison.
Additionally, a reference medium from which KSFM is derived from, Molecular, Cellular, and
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Development Biology (MCDB) 153 was used for comparison. Among the major metabolic
requirements, the amino acids, vitamins, trace elements, bulk organic ions, and other organic
compounds were relatively similar.19 However, the components listed were found exclusively in
the defined medium of L. acidophilus: guanine, adenylic acid (adenosine-5’-phosphate),
cytidylic acid (cytidine,(2’,3’)-phosphate), uracil, spermidine phosphate, Tween 80 (polysorbate
80), sodium citrate, potassium hydroxide, sodium thioglycolate, thymine, and deoxyguanosine.19
According to the reference, Tween 80, a surfactant that increases the efficiency of nutrient
absorption in Lactobacilli, was essential for the growth of L. acidophilus, and this metabolic
requirement could not be replaced with oleic acid from which it is derived from.19 The
auxotrophic nature of L. acidophilus for uracil could not be established, however, no stable
growth was observed upon its absence.19 Aside from that, KOH was only required to neutralize
the media components to pH 7.0. But more importantly, thymine was required in the absence of
folic acid.19 Deoxyguanosine was required in higher concentrations if thymine was not present.19
Non-essential components for growth included adenine, cytidylic acid, thioglycolate, spermidine
phosphate, and guanine; pyridoxine and citrate were also non-essential components but were
extremely practical for lasting growth.19 Overall, a large emphasis is placed on the metabolic
requirements of L. acidophilus with regards to nucleotides and nucleobase derivatives, as they
prove essential or beneficial to growth – an idea further explored in the EZ metabolic study with
regards to the biosynthetic capabilities of L. acidophilus.
In order to determine not only the metabolic requirements but to also highlight the
considerable anabolic deficits of L. acidophilus, an EZ metabolic study was performed using an
RDM kit to exclude certain metabolic groups and to analyze growth in lieu of an undefined
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medium, such as MRS. No growth was noted in Tubes 1-3, serving as negative controls, which
verified the lack of contamination of the reagents used. Mild turbidity was observed in tube 4,
which acted as a positive control to demonstrate the viability of the pilot strain in its established
culture medium; no turbidity was observed in tube 5, which further confirmed the lack of growth
and potential disruption of viability in CCM. Mild turbidity was also observed in tube 6; acting
as a control for the remainder of the experiment, the pilot strain was inoculated in full RDM to
confirm that the mixture provided all necessary metabolic components to support growth –
therefore, the absence of growth upon removal of certain metabolites could be attributed to the
removal of those respective components. Similar to the growth study of L. acidophilus in equal
proportions MRS and CCM, the pilot strain was also inoculated in equal proportions of the full
RDM and MRS in tube 7 to rule out the former as an inhibitor; heavy turbidity was observed
which suggests not only that both cultures mediums are able to support growth but also that
either the full RDM or a combination of both mediums may be optimal choices in future studies.
In tube 8, the pilot strain was inoculated in the full RDM minus the nucleotide component to test
if the pilot strain was auxotrophic for either purines or pyrimidines. No observable turbidity was
noted, and further genomic analysis of the representative NCFM strain revealed complete
pathways for the de novo synthesis of purines yet only partial biosynthetic pathways for
pyrimidine synthesis could be assembled.8 Consequently, it has been noted that many
Lactobacilli are auxotrophic for either purines or pyrimidines as many strains lack the ability to
reduce ribonucleotides into deoxyribonucleotides for DNA synthesis.20,21 Moreover, in a
literature review of nucleotide metabolism in Lactobacilli, the genes encoding pyrimidine
biosynthesis were repressed upon growth in rich medium, such as that of the full RDM mixture –
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while no conclusive mechanism has been attributed to this phenomenon, it further stresses the
interdependence between several catabolic pathways and nucleotide biosynthesis.20 Therefore, it
has been postulated that Lactobacilli utilize several transporters to utilize exogenous sources of
nucleobases. In a nutrient consumption pattern study of L. acidophilus strain KLDS 1.0738,
uracil and thymine had the highest consumption rates, and guanine and uracil were among the
most abundantly consumed nucleotides.21 However, decreased consumption of adenine
nucleotides, as well as 2’-deoxyguanosine monohydrate, glucose, and other vitamins, was
associated with increasing growth rates, highlighting the more effective use and metabolic
efficiency of pathways upon increased biomass.21 In tube 9, the supplement EZ mix was omitted
from the culture to investigate if L. acidophilus is auxotrophic for all amino acids; however,
significant turbidity was noted in this case. Several in silico studies have revealed that L.
acidophilus strain NCFM is only capable of the de novo synthesis of cysteine, serine, and
aspartate; from these three amino acids, seven other amino acids can be synthesized (no
conversion pathways could be found for the other ten amino acids).8 These studies are further
supported by the high degree of complexity of amino acid/protein transporters, as well as
peptidases and proteases, found in the organism. In total, nine types of ATP-binding cassette
(ABC) transporters were found.8 Therefore, it is likely that L. acidophilus may utilize and rely on
this complex system of transporters for the supply of amino acids. These studies highlight the
pilot strain’s degree of auxotrophy, further complimenting its presence and adaptation to the
nutrient-rich environment of the upper gastrointestinal tract.8
The viability of L. acidophilus was represented by CFU/mL, calculated using the colony
count averages and applying dilution factor and spot corrections. In MRS, an initial bloom to a
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turbid 109 CFU/mL of the culture is noted in the first 24 hours, which provides evidence that
MRS supports the growth of the pilot strain and also that L. acidophilus is viable in human tissue
in vitro conditions, mainly 5% CO2 exposure and no shaking – representative of a more
anaerobic microenvironment. However, a 10-fold decrease in viability and death of a significant
portion of the culture is noted around 48 hours. There are several potential explanations for this,
the most prominent being that L. acidophilus is a homofermenter of carbohydrates to lactic acid
– metabolic studies have concluded that growth stops below a pH of 3.0, which can be attributed
to the buildup of lethal amounts of lactic acid.15 This is further supported by probiotic viability
studies that found L. acidophilus and L. casei to be among the most sensitive probiotic organisms
at low pH levels, with L. acidophilus demonstrating a significant decrease in viability at pH 2.22
A similar trend was noted in the CCM culture, as we see a significant decrease in viability albeit
not as extreme. No decrease in viability after 24 hours of incubation was observed, which
confirmed that CCM is not an inhibitor, as supported by the previous growth study. Notably, a
small increase in viability was observed; this may be attributed to the change in environmental
conditions in the Andl lab incubator explained above – this may have led to decreased gas
exchange rates, catering to a more anaerobic microenvironment. The observation that both
culture mediums can only support growth for a short period of time may prove valuable for
future in vitro studies where the overgrowth and over-colonization of L. acidophilus on epithelial
surfaces is not a desired outcome. On the other hand, if more robust growth is desired, MRS
broth is an additional tool to achieve a desired colony concentration.
A workflow was established to evaluate the pilot strain’s response to human tissue
culture media and this research has positioned the lab to characterize the transcriptional and
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adaptive responses of the pilot strain to the human epithelial environment. The pilot strain
revived from the ATCC was validated by Sanger sequencing to be the strain implicated in head
and neck cancers, and baseline growth rates in conventional medium and standard conditions
were established for the organism – a 100 μL culture volume under low-evaporation lids. These
growth studies suggest that L. acidophilus may grow best anaerobically, proving helpful in future
studies analyzing the anaerobic tumor microenvironment. Moreover, we have illustrated that
human tissue culture media supports little, if any, growth of the pilot strain but more importantly
does not act as an inhibitor. This has led us to highlight the anabolic deficits of L. acidophilus
and analyze the metabolic requirements that need to be fulfilled in future experiments.
Furthermore, monitoring the viability of L. acidophilus in co-culture conditions in a human cell
incubator has allowed us to set parameters for the colonization of this bacterium on epithelial
surfaces, giving us more control of bacterium concentrations in future in vitro experiments.
In the future, we would like to identify the four ribosomal RNA loci and mark them in the
annotated reference genome for comparison to our V3-V4 Sanger sequence to allow for further
confirmation of the pilot strain. Moreover, to further explore the increase in viability of the L.
acidophilus in CCM, we would like to incubate two replicate samples of each plate under aerobic
and anaerobic conditions; comparison of the CFU/mL of each plate will help confirm whether
the increase in viability is due to the change in environmental conditions or if CCM allows for
moderate growth of the bacterium. The remainder of this thesis summarizes the use of microbes
in cancer treatment, including their proclivity to inhabit tumors and the use of bacteria-derived
anticancer agents, and explores both aspects of the causality dilemma surrounding dysbiosis and
carcinogenesis.
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Microbial-Based Cancer Therapy
Tumor Visualization and Treatment
The idea that microbes can reside within tumors and cancerous tissues has been
recognized for the last several decades.4 One hallmark study observed certain strains of E. coli,
Listeria monocytogenes, Salmonella typhimurium, and Vibrio cholerae entering and replicating
within tumor in mice, visualized with luciferase-catalyzed luminescence and green fluorescent
protein fluorescence. These microbes were later observed to replicate solely within these tumors
despite having been well-distributed within the first few minutes after injection.23 One prominent
theory is that these microbes actively sought out the immune-free microenvironment of
cancerous tissue. And contrary to previous reports, these microbes did not require any genetic
mutations to alter their viability within the tissue.23 Moreover, numerous studies have concluded
that the anaerobicity of the tumor microenvironment is the most prominent factor in bacterial
aggregation – initial access and subsequent survival and replication was found to be based on the
degree of tumor vascularization as well as the degree of immune system presence.23 In addition
to the tumor-specific replication and real-time visualization of cytosolic vaccinia virus, one
possible application of this microbial behavior is their use as a molecular diagnostic for cancer –
coined a “tumor-seeking” ability as bacteria have been observed to migrate past mucosal barriers
to enter tumors.2,4 Also, these bacteria and viruses can be designed not only as therapeutic gene
carriers for the treatment of cancer but also as site-specific detectors and visualizers of primary
and metastasized tumors. This ability has shown success in detecting small nodules, such as 0.5
mm3 nodules on the lung surfaces of tumor-bearing mice.23
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Cancer therapy utilizing microbes was dismissed early on due to complications regarding
the dose required for efficient use in balance with toxicity and other adverse side-effects. First
described by William B. Coley in 1890, the microbial-based treatment of cancer was explored
using sterile filtrates from Clostridium histolyticum.24 Coley noticed tumor regression and
attributed it to anti-cancer bacterial enzymes present in the filtrate. This was further explored
when C. histolyticum spores were injected into transplanted mouse sarcomas, resulting in
oncolysis; however, toxicity still proved to be a problem, which was later resolved with daily
subcutaneous antitoxin injections.25 The obstacle of toxicity was overcome in 1967 when
researchers using Clostridium oncolyticum M55 in transplanted tumors in animal models
proposed three universal conditions for the success of microbial-based cancer therapy. Success
was based on 1) maintaining a threshold in tumor size (3 cm3 or 2 g of tumor weight), 2) a spore
dosage range of 106-9, and 3) injecting spores both intratumorally and intravenously.24 These
conditions, in addition to combining the strain spores with antineoplastic antimetabolites and
other chemotherapy agents, raising the intratumoral temperature, or reducing oxygen levels
within viable limits, resulted in increased tumor lysis.24,26 These studies built the foundation of
more modern techniques of microbial-based cancer therapy; and now, attenuated and precisely
engineered strains of Clostridium, Bifidobacterium, Salmonella, Mycobacterium, Bacillus, and
Listeria are now the primary candidates for targeting cancer cells due to their proclivity to live in
the hypoxic cores of solid tumors – areas that chemotherapy and radiation have difficulty
targeting.24 For the last two decades, engineered Clostridial strains have remained the focus of
microbial-based cancer therapy, particularly due to their efficacy when combined with radiation
– this is critical as radiation is especially dependent on oxygenation. It has been established that
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hypoxic cells are several times more resistant to ionizing radiation, so highly anaerobic, solid
tumor centers are difficult to target. Consequently, a combination of radiation and microbes may
effectively target all areas of a solid tumor.27 A combinatorial approach using Clostridium novyiNT spores, a highly oxygen-sensitive strain with its α-toxin removed, and a mixture of a DNAdamaging drug and anti-vascular agent, was tested in avascular mice tumors that resulted in
extensive tumor necrosis – a treatment strategy coined combination bacteriolytic therapy
(COBALT).28 Another genus that has shown promising anticancer effects is Bifidobacterium, the
most abundant genus in the human colon. Selected based not only on its selective growth in
hypoxic tumors masses but also due to its ability to heighten host immune response,
Bifidobacterium has been shown to enhance the activity of NK cells and magnify the activity of
IL-2, INFγ, and INFα.24,26
Additionally, several genes cloned into Bifidobacterium plasmids have been used in gene
therapy; the plasmid pBLES100 has been used to clone cytosine deaminase, allowing
Bifidobacterium longum to convert the prodrug 5-fluorocytosine (5-FC) into 5-fluorouracil (5FU), a medication used heavily in the treatment of head-and-neck cancers – this highlights this
genus’ efficacy as both a tumor-specific gene and prodrug delivery system.29,30 A hallmark strain
of microbial-based cancer therapy is Mycobacterium bovis Bacillus Calmette-Guérin (BCG), a
standard of care for the treatment of bladder cancer. BCG is inserted using a urethral catheter to
stimulate an increasingly large immune response upon the initial binding to fibronectin
attachment protein and subsequent internalization by urothelial and inflammatory cells; this leads
to a surge of cytokine and neutrophil concentration, dependent on a functional immune
system.24,31,32
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Bacteria-Derived Anticancer Agents
An additional facet of microbial-based cancer treatment focuses on the use of bacteriaderived products as anticancer agents. Certain strains are able to produce a multitude of enzymes,
cytotoxic factors, antibiotics, and other secondary metabolites that can be used to target several
aspects of tumor formation and spread.24 For example, several bacterially derived products are
capable of interfering with metastasis, a highly specific process heavily governed through
chemokines. By inhibiting the binding of chemokine and adhesion receptors, bacterial proteins
can prevent the migration of malignant cells. This was observed in a class of bacterial proteins
known as staphylococcal superantigens-like (SSL), produced by Staphylococcus aureus; these
proteins were found to bind to the CXCR4 chemokine receptors in human T acute lymphoblastic
leukemia, lymphoma, and cervical carcinoma cell lines, thereby inhibiting tumor cell
migration.33
Bacterial enzymes, even those as ubiquitous from parts of catabolic pathways, are strong
contenders for anticancer agents.24 For example, arginine is an amino acid heavily implicated in
tumor initiation, tumor-cell adhesion, and tumor-induced immunosuppression; produced by
Mycoplasma arginine (Ma-ADI), the enzyme hydrolase arginine deiminase (ADI) breaks down
L-arginine into L-citrulline and ammonia and has been used for the treatment of both in vitro and
in vivo tumors in renal cell carcinoma and hepatocellular carcinoma.24,34 These types of cancers
do not express their own biosynthetic enzymes for arginine synthesis, such as argininosuccinate
synthetase, making them susceptible to ADI.24,34 Moreover, bacterial antibiotics are heavily
implicated as anticancer agents through their modulation of the proto-oncogene Ras and the
subsequent anchorage of Ras on the plasma membrane.24 For instance, Ras requires farnesylation
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and the antibiotic Manumycin A, produced by Streptomyces parvulus, acts as a
farnesyltransferase inhibitor (FTI) and has shown success in reducing the number of pancreatic
tumors in mice and enhancing apoptosis in myeloid leukemia cells.35,36 There are hundreds of
metabolites of interest that have yet to be studied, but all share the same general mechanism of
action: targeting a specific pathway within a tumor cell line. The workflow for this type of
research is a blend of combinatorial chemistry and assays to target major mechanisms such as
DNA replication, cell division, and apoptosis.24
Dysbiosis: Cause of Cancer Progression
A darker side compared to microbes’ use in cancer therapy exists as dysbiosis can cause
cancer progression. Changes in the human microbiome have been linked to several disease
states, the premise being that an imbalance in the number of “protective” and “harmful” species
is thought to be the underlying cause of chronic disease – an alternative model to Koch’s
postulates.37 Those who maintain a normal flora during cancer progression, as seen in cases of
oral and colorectal cancer, have a much better prognosis than those who do not; this has also
been reported to be the case in inflammatory bowel disease, obesity, diabetes, atopic dermatitis,
and psoriasis.4,38,39 Once commensal strains of microbes can also become pathogenic, yet many
strains are opportunistic and retain their pathogenicity and look for openings in the host immune
system; pathogenic strains have been reported to associate with commensal biofilms to avoid
triggering an immune response.2,40,41
It has also been postulated that dysbiosis not only leads to disease persistence but also to
progression.39 Similar to the established relationship between H. pylori and gastric
adenocarcinoma, it is though that Campylobacter species can lead to the progression of
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esophageal adenocarcinoma (EAC).42 Clinical trials investigating the pathogenicity of
Campylobacter concisus and Campylobacter rectus presented numerous isolated strains,
separated based on adherent and invasive pathotypes, that are thought to be involved in EAC
progression.42 Esophageal inflammation has been associated with changes in the microbiota,
such as Barrett’s esophagus (BE), gastroesophageal reflux disease (GERD), and cancer.38,43 In
studies examining the development of EAC, alterations in the microbiome in GERD – and
subsequent chronic exposure to these conditions – were found to be carcinogenic.37 Similarly,
over 21 distinct bacterial species were noted in one patient sample with BE.44 Microscopic
examination of esophageal biopsies revealed Gram-negative cocci and coccobacilli in close
association with the distal squamous epithelium of the esophagus and Gram-positive cocci
concentrated in the intestinal-type gland lumen.44 Additionally, dysbiosis can lead to widespread
systemic diseases. In a study on smoking and the oral microbiome, oral dysbiosis was not only
identified to lead to inflammation states such as periodontitis, but it was also associated with
diseases of the lungs, digestive tract, and cardiovascular system.18,40 In particular, the oral
pathogen Porphyromonas gingivalis, detected using immunohistochemistry and the presence of
lysine-specific gingipain, was located in 61% of cancerous tissues; it was also found to be
associated with oral squamous cell carcinoma (OSCC) tumorigenesis and esophageal squamous
cell cancer (ESCC), and was selected as a candidate for an ESCC biomarker.18,39,40,45 There are
several mechanisms proposed to explain the carcinogenesis mediated by dysbiosis: production of
carcinogenic and genotoxic compounds, activation and metabolism of pro-carcinogenic
compounds, induction of chronic inflammation, and influence on eukaryotic cellular signaling.
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Production of Carcinogenic and Genotoxic Compounds
Several microbes are capable of promoting a host inflammatory response through the
production of carcinogenic compounds as well as inducing genetic damage through genotoxic
compound production.2,4,5,18,39,46,47 Many species are able to catalyze nitrosation reactions, the
production of N-nitroso carcinogenic compounds from precursor nitrites, amines, amides, and a
variety of organic compounds. This activity was observed in strains isolated from the human
trachea, urine, blood, and feces from microbes such as E. coli (18 out of 19 total experimental
strains), Pseudomonas aeruginosa, and the genus Proteus.2,48 For these reactions, it was
proposed that endogenous nitrosation was dependent on the pKa of the respective amine.2,48
Activation and Metabolism of Pro-Carcinogenic Compounds
Additionally, carcinogenesis by dysbiosis may be explained not only by the production of
carcinogenic agents but also the activation and metabolism of pro-carcinogenic compounds, a
process mediated through xenobiotic metabolic enzymes produced by certain bacterial
species.2,4,5,18,46 A hallmark example of this process is the metabolism of ethanol into
acetaldehyde – ethanol itself is not a carcinogen but acetaldehyde has been shown to be
carcinogenic in both animal models and in vitro studies. The reaction is catalyzed by alcohol
dehydrogenase, naturally produced and found in human epithelial tissue, the liver, lower
intestinal tract, and kidneys.2,4,49 Yet it has been reported that acetaldehyde can be produced by
oral bacteria.50,51 In a study analyzing the levels of acetaldehyde in patient saliva after ingestion
of ethanol to mimic social drinking, significantly higher amounts of acetaldehyde were found in
those compared to controls; moreover, acetaldehyde production was markedly lower after
patients underwent a three-day use of chlorhexidine, an antiseptic mouthwash.52 In the same
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study, in vitro trials revealed a linear relationship between acetaldehyde production and ethanol
concentration.52 These results were further confirmed by a study exploring bacterial taxa
associated with smoking; researchers found that smoking increased abundance levels of Grampositive bacteria, which are more significant contributors of ethanol metabolism.49 Thus,
smokers were found to have greater acetaldehyde production, with estimates as high as 50-60%
compared to controls.49 Streptococci, Gram-positive aerobic bacteria, yeast, Neisseria species,
and many other strains are also reported to have high levels of alcohol dehydrogenase, resulting
in DNA damage and mutagenesis to secondary epithelial hyperproliferation.2,4 Even outside of
the oral cavity, the highest metabolic activity of ethanol into acetaldehyde has been noted in the
lower intestine by fecal bacteria.50 This overwhelming amount of acetaldehyde has been found to
decrease the number of functional cells in colonic crypts, leading to compensatory
hyperproliferation and proclivity towards colorectal cancer.50
Induction of Chronic Inflammation
While acute inflammation plays a role in the innate immune system to defend the body
against cancer, chronic inflammation has a promoting effect on cancer, allowing for the selection
and subsequent expansion of tumors.2,4,5,18,46 Bacterial cells alone can induce inflammation by
stimulating the immune system, promoting the mutagenic effects of cytokines.53 Several
examples of site-specific inflammation caused by microbes have been noted in the literature. A
bacterial infection by Propionibacterium acnes has been associated with prostatic cancer through
the induction of inflammation.53 Histological examination of resected prostatic tissue samples
from patients with prostate cancer revealed significantly higher levels of inflammation in those
culture-positive for P. acnes.53 Upon further analyses, the isolates of P. acnes from patient
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samples differed both phenotypically and genetically from cutaneous isolates, suggesting that a
specific inflammatory subtype/strain might be a responsible agent.53 Similarly, Chlamydophila
pneumoniae and Streptococcus bovis play a role in the inflammatory response and
carcinogenesis in the lungs and colon, respectively.4 C. pneumoniae, an intracellular human
pathogen that is responsible for acute respiratory infections, has been found to induce gene
expression of proinflammatory cytokines, such as IL-8, IFN-γ, and TNF-α in a respiratory
carcinoma cell line; furthermore, the inactivated form of this microbe could still induce
significant cytokine gene expression.54 S. bovis, historically a low-grade pathogen, entered the
spotlight when the bacterium was found in 25-80% of patients with colorectal tumors; upon
proteomic analysis, twelve represented proteins were found to trigger the release of IL-8 and E2
prostaglandins in human epithelial colonic Caco-2 cells.55 Lastly, strains of Streptococcus with
inflammatory properties in malignant tissue from the oral region were isolated.56 Strains of S.
anginosus and S. mitis were preferentially seen to infect cancerous esophageal tissues, thought to
then initiate inflammation through the stimulation of basal and suprabasal cells; these microbes
were also found to promote inflammatory cytokines in esophageal cell lines.56 This association
had led to the proposed theory that clearance of these tissues from microbes may decrease local
and even regional recurrence of esophageal cancers.4,56
Influence on Eukaryotic Cellular Signaling
The final major mechanism of carcinogenesis mediated by dysbiosis is the influence of
microbes on eukaryotic cellular signaling, a critical process in tumorigenesis.2,4,5,18,46 These
pathways have been observed to be influenced by several bacterial species through the activation
of mitogen-activated kinase pathways that increase the levels of cellular transformation; these
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same mitogenic compounds are produced by neoplastic cells that promote neoangiogenesis and
lymphangiogenesis, processes heavily upregulated in tumorigenesis.2,57 P. gingivalis, a Gramnegative anaerobe, contains highly specific proteins and lipopolysaccharides that stimulate
human fibroblasts to proliferate in in vitro studies.4,58 For example, the mediator protein
fibroblast-activating factor (FAF), isolated from the outer membrane vesicles of this microbe, is
thought to act as a competence factor and has been observed to increase thymidine uptake in
human gingival fibroblasts and proliferation in human skin fibroblasts and umbilical vein
endothelial cells.4,58 Additionally, P. gingivalis is seen to accelerate tumorigenesis through the
upregulation of cyclins and activation of cyclin-dependent kinases (CDKs).46,59 Acting through
long fimbriae (FimA adhesins), P. gingivalis increased levels of phosphoinositide 3-kinase
(PI3Ks) and phosphoinositide-dependent protein-serine kinase 1 (PDK1), leading to rapid
acceleration through the S-phase of the cell cycle.46,59 P. gingivalis has also been seen to both
increase the expression of and activate proMMP9, the inactive form of matrix metalloproteinase
9, using gingipain proteases. MMP9 is a collagenase that is thought to promote cellular invasion
in OSCC by degrading the extracellular matrix and basement membrane – a process involved in
the metastasis of tumor cells.46,60 P. gingivalis induced proMMP9 production by activating the
ERK1/2-Ets1, p38/HSP27, and proteinase-activated receptor 2 (PAR2)/NFκB cellular
pathways.46,60 One of the largest influences on cellular signaling is a microbe’s ability to promote
proliferation through the secretion of virulence factors or by impeding apoptosis.2,4 For example,
the toxin cytotoxic necrotizing factor 1 (CNF1) secreted by E. coli, activates the p21 Rho GTPbinding protein through the deamidation of glutamine; this activation promotes the assembly of
actin and contractility of epithelial cells – but more importantly, CNF1 was found to modulate
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the activity of the Bcl-2 family of antiapoptotic proteins.61 Similarly, Mycoplasma fermentans, a
wall-less microbe, was shown to reduce the activity of TNF-α-induced apoptosis in a human
myelomonocyte cell line, mediated through a significant reduction in mitochondrial inner
transmembrane potential.62 Interestingly, these effects were observed when cells were infected
with either live M. fermentans or treated with sonicated, inactive M. fermentans.62
Dysbiosis: Effect of Cancer Progression
Despite the clear focus on the mechanisms that bacteria use to propagate cancer, there is
no clear consensus on shifts in the diversity of the microbiome, particularly the oral and
esophageal microbiome, in association with cancer. Equally important are the changes in the
microbiome as a result of cancer progression; the following literature review will explore the
other side of the causality dilemma in the relationship between carcinogenesis and dysbiosis.
Oral Microbiota
With respect to the oral region, a healthy microbiome is characterized by the phyla
Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria, assessed using
culture-independent methods such as next-generation 16S rRNA sequencing.5 However,
different culture methods, such as 16S sequencing, biopsies, swabs, and saliva samples, have
presented contrasting results with respect to shifts in the microbiome upon carcinogenesis. For
example, in a study utilizing 16S rDNA hypervariable region amplicons to monitor abundance
levels in both cancerous and pre-cancerous lesions, lower levels of Firmicutes, such as
Streptococcus, and Actinobacteria, such as Rothia, were observed in those with oral cancer.5
Significant decreases in these same groups were observed in oral pre-cancerous lesions but not
when compared to contralateral sites from control groups.5 Yet in a study analyzing the
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microbiome in OSCC where DNA obtained from both biopsies and deep-epithelium swabs was
sequenced, the genus Fusobacterium and P. aeruginosa was abundant compared to normal
samples.63 F. nucleatum was observed in higher levels on OSCC lesion surfaces – while this
conclusion had been reported in previous studies, researchers were able to designate the
subspecies polymorphum and vincentii to OSCC.63 Even more disparate results were obtained in
a study utilizing unstimulated saliva samples from OSCC-free and OSCC-positive subjects,
where oral cancer subjects had significantly elevated levels of Capnocytophaga gingivalis,
Prevotella melaninogenica, and S. mitis, compared to controls.64 Additionally, these species were
capable of predicting the presence of OSCC lesions with 80% diagnostic sensitivity and greater
than 82% specificity.64 Combined with earlier studies with the same resounding conclusions,
these authors postulated that oral cancers such as OSCC have a greater effect on the composition
of the salivary microbiome than both smoking and periodontal infections.64 This discontinuous
trend is further promoted by a study utilizing V4-V5 PCR amplicons to analyze stimulated saliva
samples from OSCC patient that revealed a greater abundance of the following genera:
Streptococcus, Gemella, Rothia, Peptostreptococcus, Lactobacillus, and Porphyromonas.65 In
regard to specificity, species such as Exiguobacterium oxidotolerans, Pseudomonas
melaninogenica, Staphylococcus aureus, and Veillonella parvula were found exclusively in oral
cancer tumors.66
Esophageal Microbiome
The literature is relatively more consistent with respect to the effects of cancer on the
esophageal microbiome. As summarized above, several reviews have noted the presence of the
genus Streptococcus as well as the phylum Firmicutes to inhabit the healthy esophageal
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microbiome.46,67 Assessments of the major species in association with cancer and other
esophageal disease states have revealed enrichments of entire taxa or the presence of unique
species. The analysis of rat esophageal samples using PCR coupled to electrospray ionization
mass spectrometry and further confirmation by fluorescence in situ hybridization revealed
several major genera and species present – the most notable being the increased prevalence of E.
coli in EAC.68 Additionally, DNA extractions from gastric corpus tissues analyzing microbiota
patterns in early ESCC and esophageal squamous dysplasia (ESD) revealed increase abundances
of the orders Clostridiales and Erysipelotrichales.69 Studies have gone further to note
associations between the esophageal microbiota not only with disease but also with cancer
predisposing states in the esophagus and stomach.70 For instance, two predisposing states
focused on for ESCC were 1) serum pepsinogen I/pepsinogen II ratio (PGI/II), a predictor of
gastric cancer where lower ratios are a marker for chronic atrophic gastritis, and 2) ESD, the
precursor to ESCC.70 An overall lower level of microbial richness, defined as the number of
bacteria genera per sample, was associated with lower PGI/II ratios and those with ESD.70
Moreover, decreased abundance levels of the genera Lautropia, Bulleidia, Catonella, and
Cardiobacterium, and a relative decrease in overall microbial diversity, were found in ESCC
fasting saliva samples compared to controls.71
Universal Changes
Among the noted site-specific shifts in the microbiota thought to be caused by
carcinogenesis, studies have also focused on universal changes in the abundance of bacteria in
cancer. One prominent theory is that these shifts are associated with changes in bacterial
receptors, such as specific cell membrane glycoconjugates.2,46 Therefore, when cells undergo
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dysplasia, the subsequent changes in cell receptors will bind specific bacteria – thought to be in
the same highly selective manner that enzyme and substrate interact.2,46 Consequently, changes
in cell receptors give rise to shifts in the composition of the microbiome, marking their additional
potential use as biomarkers for cancer.4,5,18,63 In studies examining universal shifts in the
microbiota, an increase in the levels of Fusobacterium in all cancer patients was observed.5,63
However, an overall loss of richness and diversity were noted in the microbiota of those with
HNSCC.18 In a study utilizing 16S rRNA sequencing from previously selected species from
culture isolates, patients with EAC retained similar species to controls but experienced overall
decreases in microbial diversity – with the exception of an increased abundance of Lactobacillus
fermentum.67
However, with regards to biofilm formation, the literature notes a wholly opposite trend –
an extensive increase in bacterial diversity. In OSCC tumors, biofilms contain a wider variety of
bacteria present.4 Biofilms present in keratinizing squamous cell carcinoma lesions harbored
increased numbers of both aerobes and anaerobes compared to healthy mucosal surfaces.2,72
Specifically, the aerobic genera Haemophilus, Enterobacteriaceae, and Streptococcus, and the
anaerobic genera Veillonella, Fusobacterium, Prevotella, Porphyromonas, Actinomyces, and
Clostridium, proliferated in biofilms.2,72 Additionally, Candida albicans was found to colonize
biofilms in about a third of all tumor sites.4
Several overarching similarities and trends in microbiota shifts associated with
carcinogenesis are an important facet of this causality dilemma. Most isolate species found in the
microbiota were saccharolytic and acid tolerant and seen to thrive in the acidic tumor
microenvironment.2,47 These organisms, such as Streptococcus, are thought to contribute to the
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acidic and hypoxic tumor microenvironment.18 Moreover, the environment is thought to lead to
several bacterial groups, such as Actinomyces spp. to be outcompeted by other commensals who
favor acidic, hypoxic conditions; this was supported by a study that found relatively decreased
abundances of the genus Actinomyces and phylum Actinobacteria in HNSCC.47
Future Directions of the Field
Each year, tens of millions of individuals are diagnosed with cancer; and with cancer
representing about a fifth of all deaths in the industrialized world, a coordinated, interdisciplinary
response is vital to halt its progression.24 Bacteria have demonstrated their potential as a new
avenue for cancer treatment – personalized vessels that preferentially target tumors, encode
cloned genes, and can deliver cytotoxic drugs, miRNA, and antibodies.73 Yet they also offer both
a potential explanation for an attributable cause of cancer and a way to predict cancer
progression. It is proposed that bacterial abundance levels can be used as diagnostic biomarkers
where shifts in the microbiome upon early cancer progression will be telling of carcinogenesis.
The oral and esophageal microbiome are reportedly similar in composition, with the oral
microbiome being the focus of biomarker studies for disease in gastric cancer, pancreatic cancer,
and even colorectal cancer.67 Consequently, the oral microbiome has been selected as a candidate
biomarker for cancers of both the head and neck.67 For example, Fusobacterium nucleatum, an
abundant resident of the oral microbiome, was analyzed for its prognostic significance in
esophageal cancer; in a study utilizing qPCR to quantify 325 resected esophageal cancer tissue
samples, F. nucleatum was found to significantly associate with tumor stage progression but not
with any cultural or social habits such as tobacco or alcohol use.74 A study utilizing fasting saliva
samples to analyze high-risk areas for ESCC in China found a correlation between altered
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salivary microbiota and esophageal cancer risk.71 Whether these biomarkers are telling of a
potential timeframe to eliminate the spread of cancer or simply represent the remains of a
difficult battle, as more studies accumulate on the associative links between dysbiosis and
cancer, the current field has limited itself to solely establishing speculative links. The premise of
this interdisciplinary approach is that humans are not sterile organisms, and the fact that we
disproportionately know little of the complex community we are intimately connected to has
limited our ability to fulfill the final half of Koch’s postulates. While we cannot repeat the
hallmark experiments of Dr. Marshall, the construction of a reference community that will both
provide evidence of causative links and set the foundation of a clinical study is a step in the right
direction for resolving the causality dilemma.
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APPENDIX A: ABBREVIATIONS
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ADI: Arginine Deiminase
AIM: Applied Industrial Microbiology
ATCC: American Type Culture Collection
BCG: Mycobacterium bovis Bacillus Calmette-Guérin
BE: Barrett’s Esophagus
BPE: Bovine Pituitary Extract
CCM: Cell Culture Media
CFU/mL: Colony-Forming Units per Milliliter
CNF1: Cytotoxic Necrotizing Factor 1
EAC: Esophageal Adenocarcinoma
EGF 1-53: Epidermal Growth Factor
ESCC: Esophageal Squamous Cell Carcinoma
ESD: Esophageal Squamous Dysplasia
GERD: Gastroesophageal Reflux Disease
HMP: Human Microbiome Project
HNSCC: Head-and-Neck Squamous Cell Carcinoma
HPV: Human Papillomavirus
KSFM: Keratinocyte Serum-Free Medium
MCDB: Molecular, Cellular, and Development Biology Media
MMP9: Matrix Metallopeptidase 9
MRS: deMan, Rogosa, and Sharpe
NCFM: North Carolina Food Microbiology
OD: Optical Density
O/N: Overnight
OSCC: Oral Squamous Cell Carcinoma
PGI/II: Pepsinogen I/Pepsinogen II Ratio
RDM: Rich Defined Medium
rRNA: Ribosomal Ribonucleic Acid
SPA: Spot Plate Assay
SSL: Superantigen-Like
Tm: Melting Temperature
TNTC: Too Numerous To Count
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APPENDIX B: MRS MEDIA COMPOSITION AND PREPARATION
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Lactobacilli MRS Agar (70 g Formulation Per Liter)
• 10.0 g Proteose Peptone No. 3
• 10.0 g Beef Extract
• 5.0 g Yeast Extract
• 20.0 g Dextrose
• 1.0 g Polysorbate 80
• 2.0 g Ammonium Citrate
• 5.0 g Sodium Acetate
• 0.1 g Magnesium Sulfate
• 0.05 g Manganese Sulfate
• 2.0 g Dipotassium Phosphate
• 15.0 g Agar
• Dissolve in deionized water, heat with frequent agitation, and autoclave at 121°C for 30
minutes
• Final pH 6.5 +/- 0.2
Lactobacilli MRS Broth (55 g Formulation Per Liter)
• Consists of the same ingredients without the agar
• Dissolve in deionized water, heat with frequent agitation, and autoclave at 121°C for 30
minutes
• Final pH 6.5 +/- 0.2
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APPENDIX C: REAGENTS FOR DNA EXTRACTION
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Lysis Buffer (200 μL)
• 10 mM Tris-Cl
• 5 mM EDTA
• 0.5 mM SDS
• 10 μL/mL RNase A
Gel Melting Buffer (50 mL)
• 5.5 M Gu-SCN
• 100 mM Acetic Acid
• Adjust pH to ~5.0 with KOH (forming potassium acetate, K-OAc)
Isopropanol (200 μL)
• 95-100% isopropanol
5X Column Wash Buffer (50 mL)
• 25 mM Tris-Cl
• 100 mM NaCl
• 0.5 mM EDTA
• Adjust pH to ~8.2 with NaOH
• Prior to use, dilute to 1X with ethanol (95-100% EtOH)
4X DNA Elution Buffer
• 10 mM Tris-Cl
• 0.4 mM EDTA
• Adjust pH to ~8.1 with diluted HCl
• Prior to use, dilute to 1X with dH2O
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APPENDIX D: PRIMERS FOR TAXONOMY
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Path Tail Forward
5’ - TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGACTCCTACGGGAGGCAGCAG - 3’

Path Tail Reverse
5’ - GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGCGTGGACTACCAGGGTATCTAATC - 3’
*Bold: where the primer anneals to the genome
*Italicized: sequencing primer annealing portion
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APPENDIX E: REAGENTS FOR PCR CLEANUP BY COLUMNS
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Gel Melting Buffer (50 mL)
• 5.5 M Gu-SCN
• 100 mM Acetic Acid
• Adjust pH to ~5.0 with KOH (forming potassium acetate, K-OAc)
Isopropanol (200 μL)
• 95-100% isopropanol
5X Column Wash Buffer (50 mL)
• 25 mM Tris-Cl
• 100 mM NaCl
• 0.5 mM EDTA
• Adjust pH to ~8.2 with NaOH
• Prior to use, dilute to 1X with ethanol (95-100% EtOH)
4X DNA Elution Buffer
• 10 mM Tris-Cl
• 0.4 mM EDTA
• Adjust pH to ~8.1 with diluted HCl
• Prior to use, dilute to 1X with dH2O
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APPENDIX F: MOPS EZ RICH DEFINED MEDIUM KIT COMPONENTS
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10X MOPS Buffer (100 mL)
• 40 mM Tricine
• 0.1 mM Iron Sulfate
• 95 mM Ammonium Chloride
• 2.76 mM Potassium Sulfate
• 5 μM Calcium Chloride
• 5.25 mM Magnesium Chloride
• 500 mM Sodium Chloride
• 2.92 × 10-6 mM Ammonium Molybdate
• 4.00 × 10-4 mM Boric Acid
• 3.02 × 10-5 mM Cobalt Chloride
• 9.62 × 10-6 mM Cupric Sulfate
• 8.08 × 10-5 mM Manganese Chloride
• 9.74 × 10-6 mM Zinc Sulfate
100X Potassium Phosphate Dibasic Solution (10 mL)
• 132 mM
100X 20% Glucose Solution (10 mL)
• 20.00%
10X ACGU Solution (100 mL)
• 15 mM Potassium Hydroxide
• 1.99 mM Adenine
• 1.99 mM Cytosine
• 1.99 mM Uracil
• 1.99 mM Guanine
5X Supplement EZ (200 mL)
• 4.0 mM L-Alanine
• 26 mM L-Arginine HCl
• 2.0 mM L-Asparagine
• 2.0 mM L-Aspartic Acid, Potassium Salt
• 3.0 mM L-Glutamic Acid, Potassium Salt
• 3.0 mM L-Glutamine
• 4.0 mM L-Glycine
• 1.0 mM L-Histidine HCl H2O
• 2.0 mM L-Isoleucine
• 2.0 mM L-Proline
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50 mM L-Serine
2.0 mM L-Threonine
0.5 mM L-Tryptophan
3.0 mM L-Valine
4.0 mM L-Leucine
2.0 mM L-Lysine HCl
1.0mM L-Methionine
2.0 mM L-Phenylalanine
0.5 mM L-Cysteine HCl
1.0 mM L-Tyrosine
0.05 mM Thiamine HCl
0.05 mM Calcium Pantothenate
0.05 mM para-Amino Benzoic Acid
0.05 mM para-Hydroxy Benzoic Acid
0.05 mM 2,3-diHydroxy Benzoic Acid

Sterile dH2O
• Fill to 1 L with ~580 mL dH2O
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